Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Infigratinib acetate (BGJ398) is an orally bioavailable pan inhibitor of human FGFR with potential antiangiogenic and antineoplastic activities.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | Infigratinib acetate (BGJ398) is an orally bioavailable pan inhibitor of human FGFR with potential antiangiogenic and antineoplastic activities. |
Molecular Weight | 620.53 |
Formula | C28H35Cl2N7O5 |
CAS No. | 1310746-17-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Infigratinib acetate 1310746-17-8 BGJ 398 monohydrate BGJ-398 monohydrate BGJ398 monohydrate Infigratinib Acetate inhibitor inhibit